当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析 - 现金流量表

君实生物-U

(688180)

  

流通市值:229.92亿  总市值:297.09亿
流通股本:7.63亿   总股本:9.86亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金396,310,961.151,474,934,030.73994,903,657.69493,939,610.73
收到的税费返还-143,929,288.86143,929,288.86129,854,553.65
收到其他与经营活动有关的现金3,021,150.63122,669,834.9997,647,401.24100,460,611.03
经营活动现金流入的平衡项目0000
经营活动现金流入小计399,332,111.781,741,533,154.581,236,480,347.79724,254,775.41
购买商品、接受劳务支付的现金433,711,376.042,082,560,054.821,648,909,781.581,088,928,491.83
支付给职工以及为职工支付的现金289,136,970.781,254,991,680.89958,338,967.96657,743,224.13
支付的各项税费23,365,530.9578,513,316.8558,013,895.3441,171,147.98
支付其他与经营活动有关的现金29,696,105.83330,450,198.99235,331,895.56162,133,712.54
经营活动现金流出的平衡项目0000
经营活动现金流出小计775,909,983.63,746,515,251.552,900,594,540.441,949,976,576.48
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-376,577,871.82-2,004,982,096.97-1,664,114,192.65-1,225,721,801.07
二、投资活动产生的现金流量:
收回投资收到的现金150,000,0001,246,870,799.381,205,410,678.811,202,852,598.61
取得投资收益收到的现金-4,234,520.554,234,520.554,234,520.55
处置固定资产、无形资产和其他长期资产收回的现金净额-4,097,167.3422,123.8922,123.88
收到的其他与投资活动有关的现金14,082,716.54103,189,128.3381,168,910.7958,169,603.96
投资活动现金流入的平衡项目0000
投资活动现金流入小计164,082,716.541,358,391,615.61,290,836,234.041,265,278,847
购建固定资产、无形资产和其他长期资产支付的现金212,290,902.16832,574,528.57604,662,480.18201,430,071.66
投资支付的现金25,062,189.341,459,007,993.151,340,008,0001,230,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计237,353,091.52,291,582,521.721,944,670,480.181,431,430,071.66
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-73,270,374.96-933,190,906.12-653,834,246.14-166,151,224.66
三、筹资活动产生的现金流量:
吸收投资收到的现金-155,594,530.5155,594,530.5155,594,530.5
其中:子公司吸收少数股东投资收到的现金-3,000,0003,000,0003,000,000
取得借款收到的现金1,277,906,362.64977,095,079.63602,682,782.88214,726,408.64
收到其他与筹资活动有关的现金902,530.28207,889,063.78179,512,525.1241,299,690.39
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,278,808,892.921,340,578,673.91937,789,838.5411,620,629.53
偿还债务支付的现金30,000,000480,915,060.85389,228,852.72116,669,118.43
分配股利、利润或偿付利息支付的现金13,641,504.3738,226,802.1127,697,403.4717,998,153.66
支付其他与筹资活动有关的现金15,328,803.99109,609,030.9979,669,279.6353,355,135.28
筹资活动现金流出平衡项目0000
筹资活动现金流出小计58,970,308.36628,750,893.95496,595,535.82188,022,407.37
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额1,219,838,584.56711,827,779.96441,194,302.68223,598,222.16
四、汇率变动对现金及现金等价物的影响1,249,683.87,551,261.1821,536,381.0525,100,592.95
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额771,240,021.58-2,218,793,961.95-1,855,217,755.06-1,143,174,210.62
加:期初现金及现金等价物余额3,778,142,035.885,996,935,997.835,996,935,997.835,996,935,997.83
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额4,549,382,057.463,778,142,035.884,141,718,242.774,853,761,787.21
补充资料:
净利润--2,535,689,297.85--1,126,329,526.49
资产减值准备-126,313,501.28-36,357,648.87
固定资产和投资性房地产折旧-248,629,278.03-117,563,865.27
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-248,629,278.03-117,563,865.27
无形资产摊销-23,695,564.99-9,674,560.11
长期待摊费用摊销-17,116,437.55-8,343,984.39
处置固定资产、无形资产和其他长期资产的损失--29,406,432.28--510,895.52
固定资产报废损失-520,267-341,239.65
公允价值变动损失-149,177,392.25-27,766,182.96
财务费用--57,756,280.09--38,175,741.35
投资损失--73,990,355.55-28,070,638.56
递延所得税-125,030,970.96-55,736,737.17
其中:递延所得税资产减少-125,030,970.96-55,736,737.17
存货的减少--32,448,335.17--89,867,273.75
经营性应收项目的减少--314,417,914.33--287,260,819.66
经营性应付项目的增加-262,671,653.75--8,933,202.26
其他-19,008,838.92-18,082,857.84
现金的期末余额-3,778,142,035.88-4,853,761,787.21
减:现金的期初余额-5,996,935,997.83-5,996,935,997.83
公告日期2024-04-302024-03-292023-10-282023-08-31
审计意见(境内)标准无保留意见
TOP↑